Genus/£GNS
1D1W1MYTD1Y5YMAX
About Genus
Genus PLC, trading under the ticker GNS on the London Stock Exchange, specializes in animal genetics and biotechnology. The company, founded in 1994 and headquartered in Basingstoke, United Kingdom, operates across multiple countries offering genetically superior pig and cattle breeding stock along with state-of-the-art in vitro fertilization products. Genus PLC aims to empower customers in the livestock sector to enhance the efficiency and profitability of their operations by providing innovative genetic solutions and services.
- Ticker
- £GNS
- Sector
- Health
- Primary listing
- LSE
- Employees
- 3,190
- Headquarters
- Basingstoke, United Kingdom
- Website
- www.genusplc.com
Genus Metrics
BasicAdvanced
£1.5B
31.90
£0.71
0.90
£0.33
1.46%
Price and volume
Market cap
£1.5B
Beta
0.9
52-week high
£32.29
52-week low
£19.43
Average daily volume
220K
Dividend rate
£0.33
Financial strength
Current ratio
2.254
Quick ratio
1.246
Long term debt to equity
48.839
Total debt to equity
51.736
Dividend payout ratio (TTM)
44.42%
Interest coverage (TTM)
4.24%
Profitability
EBITDA (TTM)
96.1
Gross margin (TTM)
40.12%
Net profit margin (TTM)
7.07%
Operating margin (TTM)
12.29%
Effective tax rate (TTM)
26.28%
Revenue per employee (TTM)
£210,000
Management effectiveness
Return on assets (TTM)
5.41%
Return on equity (TTM)
9.35%
Valuation
Price to earnings (TTM)
31.905
Price to revenue (TTM)
2.221
Price to book
2.96
Price to tangible book (TTM)
4.26
Price to free cash flow (TTM)
32.581
Free cash flow yield (TTM)
3.07%
Free cash flow per share (TTM)
0.694
Dividend yield (TTM)
1.46%
Growth
Revenue change (TTM)
0.06%
Earnings per share change (TTM)
-1,253.49%
3-year revenue growth (CAGR)
0.48%
10-year revenue growth (CAGR)
5.64%
3-year earnings per share growth (CAGR)
10.66%
10-year earnings per share growth (CAGR)
3.66%
3-year dividend per share growth (CAGR)
0.93%
10-year dividend per share growth (CAGR)
5.05%
What the Analysts think about Genus
Analyst ratings (Buy, Hold, Sell) for Genus stock.
Genus Financial Performance
Revenues and expenses
Genus Earnings Performance
Company profitability
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.